PortfoliosLab logo
Hims & Hers Health, Inc. (HIMS)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US4330001060

CUSIP

433000106

IPO Date

Sep 13, 2019

Highlights

Market Cap

$9.13B

EPS (TTM)

$0.53

PE Ratio

79.02

PEG Ratio

3.85

Total Revenue (TTM)

$1.78B

Gross Profit (TTM)

$1.33B

EBITDA (TTM)

$123.98M

Year Range

$12.07 - $72.98

Target Price

$42.53

Short %

30.80%

Short Ratio

2.64

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Hims & Hers Health, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


100.00%200.00%300.00%400.00%500.00%600.00%December2025FebruaryMarchAprilMay
430.20%
88.24%
HIMS (Hims & Hers Health, Inc.)
Benchmark (^GSPC)

Returns By Period

Hims & Hers Health, Inc. (HIMS) returned 114.89% year-to-date (YTD) and 302.17% over the past 12 months.


HIMS

YTD

114.89%

1M

76.20%

6M

121.96%

1Y

302.17%

5Y*

39.21%

10Y*

N/A

^GSPC (Benchmark)

YTD

-3.77%

1M

3.72%

6M

-5.60%

1Y

8.55%

5Y*

14.11%

10Y*

10.45%

*Annualized

Monthly Returns

The table below presents the monthly returns of HIMS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202554.18%20.95%-34.46%12.01%56.98%114.89%
2024-3.60%51.98%18.63%-19.00%54.99%3.96%5.20%-30.65%25.05%2.23%71.11%-24.95%171.69%
202329.17%36.11%-11.98%16.83%-22.86%5.15%-4.57%-25.20%-6.26%-4.93%48.66%0.11%38.85%
2022-25.50%6.97%2.11%-21.01%-4.04%12.13%36.64%2.75%-12.26%-18.64%36.34%3.55%-2.14%
202130.07%-23.28%-9.20%-6.42%16.40%-24.43%-27.36%-0.38%-4.31%3.45%-16.03%0.00%-55.14%
20201.52%-0.12%-0.38%-0.30%-0.37%2.38%1.28%1.75%12.12%-13.19%3.14%38.78%47.47%
20190.71%-0.35%0.86%-0.20%1.02%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 96, HIMS is among the top 4% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of HIMS is 9696
Overall Rank
The Sharpe Ratio Rank of HIMS is 9898
Sharpe Ratio Rank
The Sortino Ratio Rank of HIMS is 9494
Sortino Ratio Rank
The Omega Ratio Rank of HIMS is 9393
Omega Ratio Rank
The Calmar Ratio Rank of HIMS is 9999
Calmar Ratio Rank
The Martin Ratio Rank of HIMS is 9595
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Hims & Hers Health, Inc. (HIMS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Hims & Hers Health, Inc. Sharpe ratios as of May 10, 2025 (values are recalculated daily):

  • 1-Year: 2.78
  • 5-Year: 0.50
  • All Time: 0.48

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Hims & Hers Health, Inc. compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.006.00December2025FebruaryMarchAprilMay
2.78
0.44
HIMS (Hims & Hers Health, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Hims & Hers Health, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%December2025FebruaryMarchAprilMay
-24.41%
-7.88%
HIMS (Hims & Hers Health, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Hims & Hers Health, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Hims & Hers Health, Inc. was 87.29%, occurring on May 11, 2022. Recovery took 528 trading sessions.

The current Hims & Hers Health, Inc. drawdown is 24.41%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-87.29%Feb 9, 2021317May 11, 2022528Jun 18, 2024845
-63.12%Feb 20, 202543Apr 22, 2025
-44.94%Jun 20, 202455Sep 6, 202446Nov 11, 2024101
-30.7%Nov 12, 20244Nov 15, 20246Nov 25, 202410
-29.36%Dec 9, 202416Dec 31, 202420Jan 31, 202536

Volatility

Volatility Chart

The current Hims & Hers Health, Inc. volatility is 34.71%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%December2025FebruaryMarchAprilMay
34.71%
6.82%
HIMS (Hims & Hers Health, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Hims & Hers Health, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Hims & Hers Health, Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 66.7% positive surprise.


-0.30-0.20-0.100.000.100.200.3020212022202320242025
0.20
0.12
Actual
Estimate

Valuation

The Valuation section provides an overview of how Hims & Hers Health, Inc. is priced in the market compared to other companies in the Household & Personal Products industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for HIMS, comparing it with other companies in the Household & Personal Products industry. Currently, HIMS has a P/E ratio of 79.0. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for HIMS compared to other companies in the Household & Personal Products industry. HIMS currently has a PEG ratio of 3.9. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for HIMS relative to other companies in the Household & Personal Products industry. Currently, HIMS has a P/S ratio of 6.2. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for HIMS in comparison with other companies in the Household & Personal Products industry. Currently, HIMS has a P/B value of 19.2. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items